Feasibility study of colestipol as an oral phosphate binder in hemodialysis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility study of colestipol as an oral phosphate binder in hemodialysis patients

Published:2015-03-25 Issue:4 Volume:20 Page:250-256
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Hood Christopher J¹²,Wolley Martin J¹³,Kam Angela L⁴,Kendrik-Jones Jamie C¹,Marshall Mark R¹²⁵

Affiliation:

1. Department of Renal Medicine; Counties Manukau District Health Board; Shanghai China

2. Faculty of Medical and Health Sciences; University of Auckland; Shanghai China

3. School of Medicine; University of Queensland; Brisbane Queensland Australia

4. Pharmacy Services; Counties Manukau District Health Board; Shanghai China

5. Baxter Healthcare Ltd; Shanghai China

Funder

Royal Australasian College of Physicians

Maurice and Phyllis Paykel Trust

Centre for Clinical Research and Effective Practice Innovation Fund

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12388/fullpdf

Reference28 articles.

1. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis;Block;Kidney Int.,2005

2. Serum phosphate levels and mortality risk among people with chronic kidney disease;Kestenbaum;J. Am. Soc. Nephrol.,2005

3. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study;Young;Kidney Int.,2005

4. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis;Goodman;N. Engl. J. Med.,2000

5. Arterial stiffening and vascular calcifications in end-stage renal disease;Guérin;Nephrol. Dial. Transplant.,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphate binders in chronic kidney disease: an updated narrative review of recent data;Journal of Nephrology;2019-12-21

2. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression;Redox Biology;2016-12

3. Drugs That Affect Lipid Metabolism;Side Effects of Drugs Annual;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3